Financial News
Latest News about MRNA
Recent news which mentions MRNA
Novavax Could Be the Biggest Bargain in the Market Right Now
January 28, 2022
From InvestorPlace
From Motley Fool
Why Novavax Stock Is Sinking Again This Week
January 27, 2022
From Motley Fool
Fractional Investment Opportunity In Beachfront Multifamily Property: Last Call To Invest
January 27, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
From Benzinga
IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology
January 27, 2022
Tickers
MRNA
From Benzinga
U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster
January 27, 2022
From MarketWatch
From MarketWatch
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
1 Top Biotech Stock Ready for a Bull Run
January 27, 2022
From Motley Fool
From Benzinga
Could Vaxart's Vaccine Pill Help to End the Pandemic?
January 27, 2022
From Motley Fool
Why Coronavirus Vaccine Stocks Topped the Market Today
January 26, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2022
January 26, 2022
From Benzinga
From Motley Fool
From InvestorPlace
Novavax Continues to Require Patience, But It Should Pay Off
January 25, 2022
From InvestorPlace
Down 57% in 1 Month, Is Novavax a Bargain Buy?
January 25, 2022
From Motley Fool
Here's What to Look For in Pfizer's Upcoming Earnings Report
January 25, 2022
From Motley Fool
Novavax Appears to be Running Out of Options
January 25, 2022
From InvestorPlace
Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today
January 24, 2022
From Motley Fool
These stocks in the S&P 500 had price swings of 10% or more Monday
January 24, 2022
From MarketWatch
Is Taiwan Semiconductor the Most Important Company on Earth?
January 24, 2022
From Motley Fool
From MarketWatch
5 Stocks Insiders Are Selling: Alphabet, Moderna And More
January 24, 2022
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
January 24, 2022
From Benzinga
Where Will BioNTech Be in 3 Years?
January 24, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.